Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Auron Therapeutics, Inc.5.6remove | Mangrove Therapeutics Inc.5.6remove | NextPoint Therapeutics, Inc.5.7remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 5.6 | 5.6 | 5.7 |
| IPO signal score | 11.2 | 11.1 | 11.3 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+3.7 | STABLE0.0 | STABLE0.0 |
| Company | |||
| Stage | private | private | private |
| Sector | Technology | Technology | Technology |
| Headquarters | Wellesley, United States | SACRAMENTO, United States | CAMBRIDGE, United States |
| Founded | not on record | 2025 | not on record |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $7M | $2M | $34M |
| Latest round | Private Placement $7M | Private Placement $2M | Private Placement $34M |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 2 | 1 | 1 |
| Confidence | 55% | 53% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.